Huib H. Rabouw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huib H. Rabouw has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Marvin E. Tanenbaum
Oncode Institute, Hubrecht Institute–KNAW and University Medical Center Utrecht, Utrecht, The Netherlands
4 shared publications - Esther N. M. Nolte-'T Hoen
Infection Biology Section, Division Infectious Diseases & Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands
3 shared publications - Jasper van Den Ende
Division of Infection Biology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands
3 shared publications - Kyra A. Y. Defourny
Division of Infection Biology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands
3 shared publications - Richard W. Wubbolts
Utrecht University
3 shared publications - Antonella F. M. Dost
Hubrecht Institute - Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 15 (3)
Development of a Live‐Cell Imaging Assay to Elucidate Spatiotemporal Dynamics of Extracellular Vesicle Fusion with Target Cells
Cells communicate via extracellular vesicles (EVs) containing functional RNAs, proteins, and lipids. Knowledge on the fate of internalized EVs, especially their capacity to fuse with target cell membranes and deliver luminal cargo, is limited. Currently available EV‐cargo delivery assays are indirect and thus unlikely to uncover molecular players and conditions that specifically control the EV‐fusion step. Here, we present a novel live‐cell imaging assay for detection of EV‐binding, ‐uptake, and ‐fusion in time and space. We employed the SunTag system for exceptional signal amplification. EV‐donor cells were engineered to tag the luminal EV‐membrane with a fluorescent label coupled to SunTag peptides. Recipient cells express fluorescent single‐chain anti‐SunTag antibody (STAb), which binds EV‐enclosed SunTag upon its cytosolic exposure. Using SunTagged EVs carrying fusogen VSV‐G, we visualize the EV‐fusion process, quantify fusion kinetics and efficiency, and determine subcellular localization of fusion events. We term this methodology the Extracellular Vesicle Fusion Spatiotemporal Imaging Method (EV‐FUSIM). In the future, this technology can support the identification of fusogenic EV‐subsets, as well as molecular players and drugs that modulate EV‐fusion, without confounding effects of post‐fusion processes. This will extend knowledge on EV‐biology and can aid in the engineering of EVs that efficiently deliver intraluminal therapeutic payloads.
- 1 March 2026
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 15 (3)
Open AccessDevelopment of a Live‐Cell Imaging Assay to Elucidate Spatiotemporal Dynamics of Extracellular Vesicle Fusion with Target Cells
Cells communicate via extracellular vesicles (EVs) containing functional RNAs, proteins, and lipids. Knowledge on the fate of internalized EVs, especially their capacity to fuse with target cell membranes and deliver luminal cargo, is limited. Currently available EV‐cargo delivery assays are indirect and thus unlikely to uncover molecular players and conditions that specifically control the EV‐fusion step. Here, we present a novel live‐cell imaging assay for detection of EV‐binding, ‐uptake, and ‐fusion in time and space. We employed the SunTag system for exceptional signal amplification. EV‐donor cells were engineered to tag the luminal EV‐membrane with a fluorescent label coupled to SunTag peptides. Recipient cells express fluorescent single‐chain anti‐SunTag antibody (STAb), which binds EV‐enclosed SunTag upon its cytosolic exposure. Using SunTagged EVs carrying fusogen VSV‐G, we visualize the EV‐fusion process, quantify fusion kinetics and efficiency, and determine subcellular localization of fusion events. We term this methodology the Extracellular Vesicle Fusion Spatiotemporal Imaging Method (EV‐FUSIM). In the future, this technology can support the identification of fusogenic EV‐subsets, as well as molecular players and drugs that modulate EV‐fusion, without confounding effects of post‐fusion processes. This will extend knowledge on EV‐biology and can aid in the engineering of EVs that efficiently deliver intraluminal therapeutic payloads.
- Open Access
- 1 March 2026
- Vol. 15 (3) , e70228
Development of a Live-Cell Imaging Assay to Elucidate Spatiotemporal Dynamics of Extracellular Vesicle Fusion with Target Cells.
Cells communicate via extracellular vesicles (EVs) containing functional RNAs, proteins, and lipids. Knowledge on the fate of internalized EVs, especially their capacity to fuse with target cell membranes and deliver luminal cargo, is limited. Currently available EV-cargo delivery assays are indirect and thus unlikely to uncover molecular players and conditions that specifically control the EV-fusion step. Here, we present a novel live-cell imaging assay for detection of EV-binding, -uptake, and -fusion in time and space. We employed the SunTag system for exceptional signal amplification. EV-donor cells were engineered to tag the luminal EV-membrane with a fluorescent label coupled to SunTag peptides. Recipient cells express fluorescent single-chain anti-SunTag antibody (STAb), which binds EV-enclosed SunTag upon its cytosolic exposure. Using SunTagged EVs carrying fusogen VSV-G, we visualize the EV-fusion process, quantify fusion kinetics and efficiency, and determine subcellular localization of fusion events. We term this methodology the Extracellular Vesicle Fusion Spatiotemporal Imaging Method (EV-FUSIM). In the future, this technology can support the identification of fusogenic EV-subsets, as well as molecular players and drugs that modulate EV-fusion, without confounding effects of post-fusion processes. This will extend knowledge on EV-biology and can aid in the engineering of EVs that efficiently deliver intraluminal therapeutic payloads.
- 1 March 2026
- Vol. 15 (3) , e70228
Open AccessDevelopment of a Live-Cell Imaging Assay to Elucidate Spatiotemporal Dynamics of Extracellular Vesicle Fusion with Target Cells.
Cells communicate via extracellular vesicles (EVs) containing functional RNAs, proteins, and lipids. Knowledge on the fate of internalized EVs, especially their capacity to fuse with target cell membranes and deliver luminal cargo, is limited. Currently available EV-cargo delivery assays are indirect and thus unlikely to uncover molecular players and conditions that specifically control the EV-fusion step. Here, we present a novel live-cell imaging assay for detection of EV-binding, -uptake, and -fusion in time and space. We employed the SunTag system for exceptional signal amplification. EV-donor cells were engineered to tag the luminal EV-membrane with a fluorescent label coupled to SunTag peptides. Recipient cells express fluorescent single-chain anti-SunTag antibody (STAb), which binds EV-enclosed SunTag upon its cytosolic exposure. Using SunTagged EVs carrying fusogen VSV-G, we visualize the EV-fusion process, quantify fusion kinetics and efficiency, and determine subcellular localization of fusion events. We term this methodology the Extracellular Vesicle Fusion Spatiotemporal Imaging Method (EV-FUSIM). In the future, this technology can support the identification of fusogenic EV-subsets, as well as molecular players and drugs that modulate EV-fusion, without confounding effects of post-fusion processes. This will extend knowledge on EV-biology and can aid in the engineering of EVs that efficiently deliver intraluminal therapeutic payloads.
- Open Access
Development of a live-cell imaging assay to elucidate spatiotemporal dynamics of extracellular vesicle fusion with target cells
Cells communicate via extracellular vesicles (EVs) containing functional RNAs, proteins and lipids. Knowledge on the fate of internalized EVs, especially their capacity to fuse with target cell membranes and deliver luminal cargo, is limited. Currently available EV-cargo delivery assays are indirect and thus unlikely to uncover molecular players and conditions that specifically control the EV-fusion step. Here, we present a novel live-cell imaging assay for detection of EV-binding, -uptake, and -fusion in time and space. We employed the SunTag system for exceptional signal amplification. EV-donor cells were engineered to tag the luminal EV-membrane with a fluorescent label coupled to SunTag peptides. Recipient cells express fluorescent single-chain anti-SunTag antibody (STAb), which binds EV-enclosed SunTag upon its cytosolic exposure. Using SunTagged EVs carrying fusogen VSV-G, we visualize the EV-fusion process, quantify fusion kinetics and efficiency, and determine subcellular localization of fusion events. We term this methodology EV-FUSIM ( E xtracellular V esicle Fu sion S patiotemporal Imaging M ethod). In the future, this technology can support identification of fusogenic EV-subsets, as well as molecular players and drugs that modulate EV-fusion, without confounding effects of post-fusion processes. This will extend knowledge on EV-biology and can aid in the engineering of EVs that efficiently deliver intraluminal therapeutic payloads.
Open AccessDevelopment of a live-cell imaging assay to elucidate spatiotemporal dynamics of extracellular vesicle fusion with target cells
Cells communicate via extracellular vesicles (EVs) containing functional RNAs, proteins and lipids. Knowledge on the fate of internalized EVs, especially their capacity to fuse with target cell membranes and deliver luminal cargo, is limited. Currently available EV-cargo delivery assays are indirect and thus unlikely to uncover molecular players and conditions that specifically control the EV-fusion step. Here, we present a novel live-cell imaging assay for detection of EV-binding, -uptake, and -fusion in time and space. We employed the SunTag system for exceptional signal amplification. EV-donor cells were engineered to tag the luminal EV-membrane with a fluorescent label coupled to SunTag peptides. Recipient cells express fluorescent single-chain anti-SunTag antibody (STAb), which binds EV-enclosed SunTag upon its cytosolic exposure. Using SunTagged EVs carrying fusogen VSV-G, we visualize the EV-fusion process, quantify fusion kinetics and efficiency, and determine subcellular localization of fusion events. We term this methodology EV-FUSIM ( E xtracellular V esicle Fu sion S patiotemporal Imaging M ethod). In the future, this technology can support identification of fusogenic EV-subsets, as well as molecular players and drugs that modulate EV-fusion, without confounding effects of post-fusion processes. This will extend knowledge on EV-biology and can aid in the engineering of EVs that efficiently deliver intraluminal therapeutic payloads.
- Open Access
Mapping the complete influenza A virus infection cycle through single vRNP imaging
Cell-to-cell heterogeneity is a common feature of viral infection that can generate enormous complexity, complicating understanding of infection progression and interpretation of differences between viral variants. To overcome these challenges, we developed a technology to visualize the infection cycle of human influenza A virus (IAV) from start-to-finish in individual living cells with unprecedented spatial and temporal resolution, which identified numerous distinct pathways through which infection can progress. We show that heterogeneous viral gene expression drives infection cycle heterogeneity, and identified genome packaging, vRNP transcriptional activation and host cell division as major determinants of gene expression variability. Our work maps out the complete IAV infection cycle, identifies the origin of infection heterogeneity and provides a broadly-applicable technology for studying IAV and other viruses.
Open AccessMapping the complete influenza A virus infection cycle through single vRNP imaging
Cell-to-cell heterogeneity is a common feature of viral infection that can generate enormous complexity, complicating understanding of infection progression and interpretation of differences between viral variants. To overcome these challenges, we developed a technology to visualize the infection cycle of human influenza A virus (IAV) from start-to-finish in individual living cells with unprecedented spatial and temporal resolution, which identified numerous distinct pathways through which infection can progress. We show that heterogeneous viral gene expression drives infection cycle heterogeneity, and identified genome packaging, vRNP transcriptional activation and host cell division as major determinants of gene expression variability. Our work maps out the complete IAV infection cycle, identifies the origin of infection heterogeneity and provides a broadly-applicable technology for studying IAV and other viruses.